REVIEW PAPER
Pharmacological Treatment for Pregnant Women who Smoke Cigarettes
BC Chan 1
,  
G Koren 1  
 
 
More details
Hide details
1
The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
CORRESPONDING AUTHOR
G Koren   

The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1X8, Canada
Publish date: 2003-09-15
 
Tobacco Induced Diseases 2003;1(September):165
KEYWORDS
ABSTRACT
Smoking has been associated with several concerns in pregnancy including miscarriage, preterm delivery and stillbirth. Unfortunately, approximately 12% of the pregnant population continue to smoke cigarettes, suggesting a need for additional therapy beyond behavioural change. This paper reviews the literature on the use of nicotine replacement therapy and bupropion (Zyban®) in the pregnant human population, the pharmacokinetics of nicotine in the pregnant woman, and current guidelines for smoking cessation for pregnant patients. There are currently four studies that have investigated the use of nicotine patch, three for nicotine gum, and registry and preliminary reports for bupropion. These studies did not show any adverse pregnancy outcomes with the use of pharmacological aid for smoking cessation. All the nicotine replacement therapy studies, with the exception of one randomized-controlled nicotine patch trial had small sample sizes and looked at shortterm use of drug in the third trimester. Two studies have examined the pharmacokinetics of nicotine in the pregnant woman. The results from these studies reveal greater nicotine metabolism in pregnant individuals who continue to smoke during pregnancy. Current guidelines from several organizations uniformly recommend that Nicotine Replacement Therapy should be considered if non-pharmacological therapies have been unsuccessful. Bupropion is recommended in pregnancy if the benefits outweigh the risks. There is a need for further studies on the safety and effectiveness of Nicotine Replacement therapy and bupropion in pregnancy. However, considering the current research and guidelines, pharmacological cessation aids should be considered if non-pharmacological therapies have not been effective.
 
REFERENCES (121)
1. Frazer T, Davis G, Goldstein H, Goldstein I: Cigarette smoking and prematurity: A prospective study. Am J Obstet Gynecol. 1961, 81: 988-96.
2. Jamieson P, Romer D: What do young people think they know about the risks of smoking?. Smoking: risk, perception and policy. Edited by: Slovic P. 2001, Thousand Oaks: Sage Publications, 51-63.
3. Martin J, Hamilton BE, Ventura SJ, Menacker F, Park MM: Births: Final Data for 2000. National Vital Statistics Reports. 2002, 50.
4. Fiore MC, Jorenby DE, Baker TB, Kenford SL: Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA. 1992, 268: 2687-94. 10.1001/jama.268.19.2687.
5. Lam W, Sze PC, Sacks HS, Chalmers TC: Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet. 1987, 2: 27-30. 10.1016/S0140-6736(87)93061-3.
6. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR: Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002, 162: 1267-76. 10.1001/archinte.162.11.1267.
7. Blondal T, Franzon M, Westin A: A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J. 1997, 10: 1585-90. 10.1183/09031936.97.10071585.
8. Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, et al: Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction. 1995, 90: 1671-82. 10.1111/j.1360-0443.1995.tb02837.x.
9. Hjalmarson A, Franzon M, Westin A, Wiklund O: Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Intern Med. 1994, 154: 2567-72. 10.1001/archinte.154.22.2567.
10. Silagy C, Mant D, Fowler G, Lodge M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994, 343: 139-42. 10.1016/S0140-6736(94)90933-4.
11. Bolliger CT, Zellweger JP, Danielsson T, van BX, Robidou A, Westin A, et al: Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000, 321: 329-33. 10.1136/bmj.321.7257.329.
12. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O: The nicotine inhaler in smoking cessation. Arch Intern Med. 1997, 157: 1721-8. 10.1001/archinte.157.15.1721.
13. Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K: Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction. 1996, 91: 1293-306. 10.1111/j.1360-0443.1996.tb03616.x.
14. Shiffman S, Gorsline J, Gorodetzky CW: Efficacy of over-the-counter nicotine patch. Nicotine Tob Res. 2002, 4: 477-83. 10.1080/1462220021000018416.
15. Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, et al: Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health. 1999, 89: 1701-7. 10.2105/AJPH.89.11.1701.
16. Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A: Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med. 1998, 7: 569-74. 10.1001/archfami.7.6.569.
17. Perng RP, Hsieh WC, Chen YM, Lu CC, Chiang SJ: Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. J Formos Med Assoc. 1998, 97: 547-51.
18. Richmond RL, Harris K, de Almeida NA: The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Aust. 1994, 161: 130-5.
19. Cepeda-Benito A: Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol. 1993, 61: 822-30. 10.1037/0022-006X.61.5.822.
20. Oncken CA, Pbert L, Ockene JK, Zapka J, Stoddard A: Nicotine replacement prescription practices of obstetric and pediatric clinicians. Obstet Gynecol. 2000, 96: 261-5. 10.1016/S0029-7844(00)00905-4.
21. Wright LN, Thorp JM, Kuller JA, Shrewsbury RP, Ananth C, Hartmann K: Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol. 1997, 176: 1090-4. 10.1016/S0002-9378(97)70407-1.
22. Ogburn PL, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, et al: Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999, 181: 736-43. 10.1016/S0002-9378(99)70521-1.
23. Schroeder DR, Ogburn PL, Hurt RD, Croghan T, Ramin KD, Offord KP, et al: Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Med. 2002, 11: 100-7. 10.1080/713605464.
24. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ: Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000, 96: 967-71. 10.1016/S0029-7844(00)01071-1.
25. Kapur B, Hackman R, Selby P, Klein J, Koren G: Randomized, Double-Blind, Placebo-Controlled Trial of Nicotine Replacement Therapy in Pregnancy. Curr Ther Res Clin Exp. 2001, 62: 274-8. 10.1016/S0011-393X(01)80011-4.
26. Manning FA, Feyerabend C: Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol. 1976, 83: 262-70.
27. Lindblad A, Marsal K: Influence of nicotine chewing gum on fetal blood flow. J Perinat Med. 1987, 15: 13-9.
28. Oncken CA, Hatsukami DK, Lupo VR, Lando HA, Gibeau LM, Hansen RJ: Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther. 1996, 59: 654-61. 10.1016/S0009-9236(96)90005-3.
29. GlaxoSmithKlein: The bupropion pregnancy registry: interim report, 1 September 1997 through 31 August 2002. Issued: December 2002. Pharmaresearch Corp Research Park, Wilmington, N.C.
30. Selby P, Hackman R, Kapur B, Klein J, Koren G: Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition. Ther Drug Monit. 2001, 23: 189-91. 10.1097/00007691-200106000-00001.
31. Dempsey D, Jacob P, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002, 301: 594-8. 10.1124/jpet.301.2.594.
32. De Guia N: Rethinking Stop-Smoking Medications: Myths and Facts. Ontario Medical Association. 1999.
33. Agency for Health Care Policy and Research: Clinical practice guideline: treating tobacco use and dependence. 2000, U.S. Department of Health and Human Services.
34. Royal College of Physicians (RCP): Nicotine Addiction in Britain. A report of the Tobacco Advisory Group of The Royal College of Physicians. 2000, London, RCP.
35. McNeill A, Hendrie A: Regulation of nicotine replacement therapies: an expert consensus. 2001, Copenhagen, World Health Organization Regional Office for Europe, 11-13. 34–37.
36. Windsor RA: Smoking, Cessation and Pregnancy. Women and the tobacco epidemic: Challenges for the 21st century. Edited by: Samet JM, Yoon S-Y. 2001, World Health Organization, 147-64.
37. McNeill A, Foulds J, Bates C: Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction. 2001, 96: 1757-68. 10.1046/j.1360-0443.2001.961217575.x.
38. Dempsey DA, Benowitz NL: Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf. 2001, 24: 277-322. 10.2165/00002018-200124040-00005.
39. Fagerstrom KO: Nicotine-Replacement Therapies. Nicotine and Public Health. Edited by: Ferrence R, Slade J, Room R, Pope M. 2000, Washington: American Public Health Association, 199-208.
40. Chow WH, Daling JR, Weiss NS, Voigt LF: Maternal cigarette smoking and tubal pregnancy. Obstet Gynecol. 1988, 71: 167-70.
41. Handler A, Davis F, Ferre C, Yeko T: The relationship of smoking and ectopic pregnancy. Am J Public Health. 1989, 79: 1239-42. 10.2105/AJPH.79.9.1239.
42. Coste J, Job-Spira N, Fernandez H: Increased risk of ectopic pregnancy with maternal cigarette smoking. Am J Public Health. 1991, 81: 199-201. 10.2105/AJPH.81.2.199.
43. Tuomivaara L, Ronnberg L: Ectopic pregnancy and infertility following treatment of infertile couples: a follow-up of 929 cases. Eur J Obstet Gynecol Reprod Biol. 1991, 42: 33-8. 10.1016/0028-2243(91)90156-F.
44. Phillips RS, Tuomala RE, Feldblum PJ, Schachter J, Rosenberg MJ, Aronson MD: The effect of cigarette smoking, Chlamydia trachomatis infection, and vaginal douching on ectopic pregnancy. Obstet Gynecol. 1992, 79: 85-90.
45. Saraiya M, Berg CJ, Kendrick JS, Strauss LT, Atrash HK, Ahn YW: Cigarette smoking as a risk factor for ectopic pregnancy. Am J Obstet Gynecol. 1998, 178: 493-8. 10.1016/S0002-9378(98)70427-2.
46. Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML: Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med. 1999, 16: 208-15. 10.1016/S0749-3797(98)00089-0.
47. Bouyer J, Coste J, Shojaei T, Pouly JL, Fernandez H, Gerbaud L, et al: Risk Factors for Ectopic Pregnancy: A Comprehensive Analysis Based on a Large Case-Control, Population-based Study in France. Am J Epidemiol. 2003, 157: 185-94. 10.1093/aje/kwf190.
48. Hadley CB, Main DM, Gabbe SG: Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol. 1990, 7: 374-9. 10.1055/s-2007-999527.
49. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, et al: Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol. 1990, 163: 130-7.
50. Williams MA, Mittendorf R, Stubblefield PG, Lieberman E, Schoenbaum SC, Monson RR: Cigarettes, coffee, and preterm premature rupture of the membranes. Am J Epidemiol. 1992, 135: 895-903.
51. Ekwo EE, Gosselink CA, Woolson R, Moawad A: Risks for premature rupture of amniotic membranes. Int J Epidemiol. 1993, 22: 495-503. 10.1093/ije/22.3.495.
52. Spinillo A, Nicola S, Piazzi G, Ghazal K, Colonna L, Baltaro F: Epidemiological correlates of pre-term premature rupture of membranes. Int J Gynaecol Obstet. 1994, 47: 7-15. 10.1016/0020-7292(94)90454-5.
53. Miller HC, Jekel JF: Epidemiology of spontaneous premature rupture of membranes: factors in pre-term births. Yale J Biol Med. 1989, 62: 241-51.
54. Karegard M, Gennser G: Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol. 1986, 67: 523-8.
55. Ananth CV, Savitz DA, Luther ER: Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol. 1996, 144: 881-9.
56. Αnanth CV, Smulian JC, Vintzileos AM: Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. 1999, 93: 622-8. 10.1016/S0029-7844(98)00408-6.
57. Cnattingius S, Mills JL, Yuen J, Eriksson O, Salonen H: The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol. 1997, 177: 156-61. 10.1016/S0002-9378(97)70455-1.
58. Saftlas AF, Olson DR, Atrash HK, Rochat R, Rowley D: National trends in the incidence of abruptio placentae, 1979–1987. Obstet Gynecol. 1991, 78: 1081-6.
59. Spinillo A, Capuzzo E, Colonna L, Solerte L, Nicola S, Guaschino S: Factors associated with abruptio placentae in preterm deliveries. Acta Obstet Gynecol Scand. 1994, 73: 307-12.
60. Voigt LF, Hollenbach KA, Krohn MA, Daling JR, Hickok DE: The relationship of abruptio placentae with maternal smoking and small for gestational age infants. Obstet Gynecol. 1990, 75: 771-4.
61. Raymond EG, Mills JL: Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand. 1993, 72: 633-9. 10.3109/00016349309021156.
62. Williams MA, Lieberman E, Mittendorf R, Monson RR, Schoenbaum SC: Risk factors for abruptio placentae. Am J Epidemiol. 1991, 134: 965-72.
63. Williams MA, Mittendorf R, Monson RR: Chronic hypertension, cigarette smoking, and abruptio placentae. Epidemiology. 1991, 2: 450-3. 10.1097/00001648-199111000-00012.
64. Himmelberger DU, Brown BW, cohen EN: Cigarette smoking during pregnancy and the occurrence of spontaneous abortion and congenital abnormality. Am J Epidemiol. 1978, 108: 470-9.
65. Kline J, Stein ZA, Susser M, Warburton D: Smoking: a risk factor for spontaneous abortion. N Engl J Med. 1977, 297: 793-6.
66. Dominguez-Rojas V, Juanes-Pardo JR, Astasio-Arbiza P, Ortega-Molina P, Gordillo-Florencio E: Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors?. Eur J Epidemiol. 1994, 10: 665-8. 10.1007/BF01719278.
67. Armstrong BG, McDonald AD, Sloan M: Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health. 1992, 82: 85-7. 10.2105/AJPH.82.1.85.
68. Windham GC, Swan SH, Fenster L: Parental cigarette smoking and the risk of spontaneous abortion. Am J Epidemiol. 1992, 135: 1394-403.
69. Chelmow D, Andrew DE, Baker ER: Maternal cigarette smoking and placenta previa. Obstet Gynecol. 1996, 87: 703-6. 10.1016/0029-7844(95)00471-8.
70. Handler AS, Mason ED, Rosenberg DL, Davis FG: The relationship between exposure during pregnancy to cigarette smoking and cocaine use and placenta previa. Am J Obstet Gynecol. 1994, 170: 884-9.
71. Kramer MD, Taylor V, Hickok DE, Daling JR, Vaughan TL, Hollenbach KA: Maternal smoking and placenta previe. Epidemiology. 1991, 1991: 3-211.
72. Meyer MB, Jonas BS, Tonascia JA: Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol. 1976, 103: 464-76.
73. Meyer MB, Tonascia JA: Maternal smoking, pregnancy complications, and preinatal mortality. Am J Obstet Gynecol. 1977, 128: 494-502.
74. Monica G, Lilja C: Placenta previa, maternal smoking and recurrence risk. Acta Obstet Gynecol Scand. 1995, 74: 341-5. 10.3109/00016349509024425.
75. Naeye RL: Abruptio placentae and placenta previa: frequency, perinatal mortality, and cigarette smoking.
76. Williams MA, Mittendorf R, Lieberman E, Monson RR, Schoenbaum SC, Genest DR: Cigarette smoking during pregnancy in relation to placenta previa. Am J Obstet Gynecol. 1991, 165: 28-32.
77. Zhang J, Fried DB: Relationship of maternal smoking during pregnancy to placenta previa. Am J Prev Med. 1992, 8: 278-82.
78. Mathai M, Skinner A, Lawton K, Weindling AM: Maternal smoking, urinary cotinine levels and birth-weight. Aust N Z J Obstet Gynaecol. 1990, 30: 33-6. 10.1111/j.1479-828X.1990.tb03192.x.
79. Castro LC, Azen C, Hobel CJ, Platt LD: Maternal tobacco use and substance abuse: reported prevalence rates and associations with the delivery of small for gestational age neonates. Obstet Gynecol. 1993, 81: 396-401.
80. Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO, Nelson KG: The effect of cigarette smoking on neonatal anthropometric measurements. Obstet Gynecol. 1995, 85: 625-30. 10.1016/0029-7844(94)00437-I.
81. Conter V, Cortinovis I, Rogari P, Riva L: Weight growth in infants born to mothers who smoked during pregnancy. BMJ. 1995, 310: 768-71.
82. Ahlsten G, Cnattingius S, Lindmark G: Cessation of smoking during pregnancy improves foetal growth and reduces infant morbidity in the neonatal period. A population-based prospective study. Acta Paediatr. 1993, 82: 177-81. 10.1111/j.1651-2227.1993.tb12634.x.
83. Aronson RA, Uttech S, Soref M: The effect of maternal cigarette smoking on low birth weight and preterm birth in Wisconsin, 1991. Wis Med J. 1993, 92: 613-7.
84. Backe B: Maternal smoking and age. Effect on birthweight and risk for small-for-gestational age births. Acta Obstet Gynecol Scand. 1993, 72: 172-6. 10.3109/00016349309013367.
85. English PB, Eskenazi B, Christianson RE: Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. Am J Public Health. 1994, 84: 1439-43. 10.2105/AJPH.84.9.1439.
86. Eskenazi B, Prehn AW, Christianson RE: Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight. Am J Public Health. 1995, 85: 395-8. 10.2105/AJPH.85.3.395.
87. Murphy NJ, Butler SW, Petersen KM, Heart V, Murphy CM: Tobacco erases 30 years of progress: preliminary analysis of the effect of tobacco smoking on Alaska Native birth weight. Alaska Med. 1996, 38: 31-3.
88. Muscati SK, Gray-Donald K, Newson EE: Interaction of smoking and maternal weight status in influencing infant size. Can J Public Health. 1994, 85: 407-12.
89. Zaren B, Lindmark G, Gebre-Medhin M: Maternal smoking and body composition of the newborn. Acta Paediatr. 1996, 85: 213-9. 10.1111/j.1651-2227.1996.tb13995.x.
90. Alameda County Low Birth Weight Study Group: cigarette smoking and the risk of low birth weight: a comparison in black and white women. Epidemiology. 1990, 1: 201-5.
91. Bakketeig LS, Jacobsen G, Hoffman HJ, Lindmark G, Bergsjo P, Molne K, et al: Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand. 1993, 72: 273-9. 10.3109/00016349309068037.
92. Bardy AH, Seppala T, Lillsunde P, Kataja JM, Koskela P, Pikkarainen J, et al: Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol. 1993, 100: 721-6.
93. Bell R, Lumley J: Alcohol consumption, cigarette smoking and fetal outcome in Victoria, 1985. Community Health Stud. 1989, 13: 484-91.
94. Brooke OG, Anderson HR, Bland JM, Peacock JL, Stewart CM: Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. BMJ. 1989, 298: 795-801. 10.1136/bmj.298.6676.795.
95. Cornelius MD, Taylor PM, Geva D, Day NL: Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology. Pediatrics. 1995, 95: 738-43.
96. Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian W, Jian-Hua M: Smoking during pregnancy: the dose dependence of birthweight deficits. Br J Obstet Gynaecol. 1996, 103: 806-13.
97. Nordentoft M, Lou HC, Hansen D, Nim J, Pryds O, Rubin P, et al: Intrauterine growth retardation and premature delivery: the influence of maternal smoking and psychosocial factors. Am J Public Health. 1996, 86: 347-54. 10.2105/AJPH.86.3.347.
98. Tenovuo AH, Kero PO, Korvenranta HJ, Erkkola RU, Klemi PJ, Tuominen J: Risk factors associated with severely small for gestational age neonates. Am J Perinatol. 1988, 5: 267-71. 10.1055/s-2007-999701.
99. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP, Davis RO, et al: Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol. 1990, 162: 53-8.
100. McDonald AD, Armstrong BG, Sloan M: Cigarette, alcohol, and coffee consumption and prematurity. Am J Public Health. 1992, 82: 87-90. 10.2105/AJPH.82.1.87.
101. Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB: The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA. 1993, 269: 1519-24. 10.1001/jama.269.12.1519.
102. Ferraz EM, Gray RH, Cunha TM: Determinants of preterm delivery and intrauterine growth retardation in north-east Brazil. Int J Epidemiol. 1990, 19: 101-8. 10.1093/ije/19.1.101.
103. Centers for Disease Control: Effects of maternal cigarette smoking on birth weight and preterm birth – Ohio, 1989. Morbidity and Mortality Weekly Report. 1990, 39: 662-5.
104. Wilcox AJ: Birth weight and perinatal mortality: the effect of maternal smoking. Am J Epidemiol. 1993, 137: 1098-104.
105. Cnattingius S, Forman MR, Berendes HW, Graubard BI, Isotalo L: Effect of age, parity, and smoking on pregnancy outcome: a population-based study. Am J Obstet Gynecol. 1993, 168: 16-21.
106. Heffner LJ, Sherman CB, Speizer FE, Weiss ST: Clinical and environmental predictors of preterm labor. Obstet Gynecol. 1993, 81: 750-7.
107. Mainous AG, Hueston WJ: The effects of smoking cessation during pregnancy on preterm delivery and low birthweight. J Fam Pract. 1994, 38: 262-6.
108. Meis PJ, Michielutte R, Peters TJ, Wells HB, Sands RE, Coles EC, et al: Factors associated with term low birthweight in Cardiff, Wales. Paediatr Perinat Epidemiol. 1997, 11: 287-97. 10.1111/j.1365-3016.1997.tb00006.x.
109. Olsen P, Laara E, Rantakallio P, Jarvelin MR, Sarpola A, Hartikainen AL: Epidemiology of pre-term delivery in two birth cohorts with an interval of 20 years. Am J Epidemiol. 1995, 142: 1184-93.
110. Shiono PH, Klebanoff MA, Rhoads GG: Smoking and drinking during pregnancy. Their effects on preterm birth. JAMA. 1986, 255: 82-4. 10.1001/jama.255.1.82.
111. Cnattingius S, Haglund B, Meirik O: Cigarette smoking as risk factor for late fetal and early neonatal death. BMJ. 1988, 297: 258-61. 10.1136/bmj.297.6643.258.
112. Malloy MH, Kleinman JC, Land GH, Schramm WF: The association of maternal smoking with age and cause of infant death. Am J Epidemiol. 1988, 128: 46-55.
113. Raymond EG, Cnattingius S, Kiely JL: Effects of maternal age, parity, and smoking on the risk of stillbirth. Br J Obstet Gynaecol. 1994, 101: 301-6.
114. Schramm WF: Smoking during pregnancy: Missouri longitudinal study. Paediatr Perinat Epidemiol. 1997, 11 (Suppl 1): 73-83. 10.1046/j.1365-3016.11.s1.10.x.
115. Cnattingius S, Forman MR, Berendes HW, Isotalo L: Delayed childbearing and risk of adverse perinatal outcome. A population-based study. JAMA. 1992, 268: 886-90. 10.1001/jama.268.7.886.
116. Walsh RA: Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol. 1994, 66: 1059-92.
117. Haglund B, Cnattingius S: Cigarette smoking as a risk factor for sudden infant death syndrome. Am J Public Health. 1990, 80: 29-32.
118. Kleinman JC, Pierre MB, Madans JH, Land GH, Schramm WF: The effects of maternal smoking on fetal and infant mortality. Am J Epidemiol. 1988, 127: 274-82.
119. Butler NR, Goldstein H: Smoking in pregnancy and subsequent child development. Br Med J. 1973, 4: 573-5. 10.1136/bmj.4.5892.573.
120. Sexton M, Hebel JR, Blackman J: Long-term consequences on cognition and physical growth associated with smoking and pregnancy. J Smoking-Related Dis. 1994, 5: 119-26.
121. Tong S, McMichael AJ: Maternal smoking and neuropsychological development in childhood: a review of the evidence. Dev Med Child Neurol. 1992, 34: 191-7.
 
CITATIONS (2):
1. Obstetricians and gynecologists’ perceptions and use of nicotine replacement therapy
James H. Price, Timothy R. Jordan, Joseph A. Dake
Journal of Community Health
2. Multigenerational effects of maternal cigarette smoke exposure during pregnancy on sperm counts of F1 and F2 male offspring
Hye Jeong Lee, Na Young Choi, Yo Seph Park, Seung-Won Lee, Jin Seok Bang, Yukyeong Lee, Jae-Sung Ryu, Seong-Jin Choi, Sang-Hyub Lee, Gwang Soo Kim, Hyun Woo Chung, Kisung Ko, Kyuhong Lee, Kinarm Ko
Reproductive Toxicology
eISSN:1617-9625